A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 3 Study of Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection in Patients With High Risk of Relapse After Radical Surgery or Ablation of Hepatocellular Carcinoma (HCC).
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 3 Study of Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection in Patients With High Risk of Relapse After Radical Surgery or Ablation of Hepatocellular Carcinoma (HCC).
The primary objective of this study was to evaluate the efficacy of anlotinib hydrochloride capsules combined with penpulimab injection (test group) versus placebo (control group) for adjuvant therapy after radical surgery or ablation in HCC patients with high risk of recurrence by assessing recurrence-free survival (RFS).
Inclusion Criteria:
Exclusion Criteria:
Bengbu, Anhui 233000, China
luzhengdr@163.com+86 13721179461
Hefei, Anhui 230000, China
Beijing, Beijing Municipality 100020, China
Beijing, Beijing Municipality 100050, China
Beijing, Beijing Municipality 100069, China
Chongqing, Chongqing Municipality 400030, China
Chongqing, Chongqing Municipality 404199, China
Nanning, Guangxi 530000, China
Guiyang, Guizhou 550008, China
Luoyang, Henan 471000, China
Jinzhou, Liaoning 121012, China
Shanghai, Shanghai Municipality 200433, China
Shanghai, Shanghai Municipality 200433, China
Xi’an, Shanxi 710038, China
Xi’an, Shanxi 710061, China
Tianjin, Tianjin Municipality 300181, China
Ürümqi, Xinjiang 830000, China
Hangzhou, Zhejiang 310000, China
liulx@ustc.edu.cn+86 18096656677
aygyf@126.com+86 13956938032
zhaoht@pumch.cn+86 13901246374
wanghongguang301@163.com+86 13717659265
chenlei@pkuph.edu.cn+86 13911995059
zhangzht@ccmu.edu.cn+86 13801060364
+86 13810108505
lidewei406@sina.com+86 13618317772
57485971@qq.com+86 13996835633
lht45182@163.com+86 18950242262
drjingfeng@126.com+86 13905029580
Yangyantd1992@163.com+86 13639395521
13993181644@139.com+86 13993181644
Zhouwc129@163.com+86 13893699909
zhengninggang0707@163.com+86 13893260496
kinghaos@126.com+86 13825066891
gaoyi6146@163.com+86 18922345399
happyxiechan@hotmail.com+86 13434383329
wufx2013@163.com+86 13707873326
LiuJun2018@126.com+86 13985519359
59434479@qq.com+86 13608512435
386421696@qq.com+86 13668526996
wujincai021@126.com+86 18889765723
13322060949@163.com+86 13322060949
zhyb88077@sina.com+86 13936588077
doctorzhangdianbao@163.com+86 15038628192
doctorssh@126.com+86 13837184328
13592616373@163.com+86 13592616373
luojia@hnca.org.cn+86 13874994359
1518364280@qq.com+86 15974220718
Huangfeizhou1009@163.com+86 18975186183
csuzld@126.com+86 17373120367
M18047660067@163.com+86 18047660067
czcxm007@126.com+86 13813587333
drlixc@163.com+86 18951999088
gusdnt@foxmail.com+86 15851392808
ntzlsbf@163.com+86 13962981592
1758771@qq.com+86 13879757375
wulqnc@163.com+86 13607912265
jl.cheng@163.com+86 13943012851
wangbcc259@163.com+86 17709870007
cmushz@163.com+86 13840650008
daicl@sj-hospital.org+86 18940251697
wuwei19700420@sina.com+86 18502460420
LnzlHxd@163.com+86 13940126803
ningfangling@126.com+86 15254311599
drzhaolei1974@163.com+86 18615216153
jijinyang@sina.com+86 13801676237
shenfengehbh@sina.com+86 13901651428
wangg1971@163.com+86 13892780368
wuli67@163.com+86 13934055258
dxlin0705@163.com+86 13709267808
shahuanchen229@xjtufh.edu.cn+86 13152167215
13991969930@126.com+86 13991969930
wuhong7801@163.com+86 18980601958
zlkgcpqlw666@163.com+86 13518388130
992437730@qq.com+86 13458406996
wangfengmeitj@126.com+86 15522242696
mail4ningning@163.com+86 15822153931
lihuikai@tjmuch.com+86 18622228639
rwx1031@163.com+86 13909911031
srrsh_cxj@zju.edu.cn+86 13805738266
arsdrell@hotmail.com+86 13567886669
lbc111@yeah.net+86 13002638081
Zhangfabiao@enzemed.com+86 13706760105
wzmcyc@126.com+86 13906650823